RNU6-871P

Across TCGA pan-cancer cohorts, RNU6-871P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-871P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNU6-871P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-871P expression acts as an unfavorable survival marker, although some lineages such as LGG and STAD show a favorable association.

LUAD, UVM, and READ are the cancer types where RNU6-871P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.103	0.757	<.001	123	view →
UVM	DFS	Tertile	All	0.032	0.762	<.001	90	view →
READ	OS	Tertile	All	0.166	0.830	<.001	81	view →
KIRC	OS	Tertile	All	0.455	0.649	<.001	72	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
LGG	DFS	Median	All	0.819	0.660	<.001	45	view →
SARC	DFS	Tertile	All	0.101	0.595	<.001	36	view →
STAD	OS	Tertile	III,IV	0.851	0.316	.015	24	view →
SKCM	DFS	Tertile	IV	0.040	0.454	.028	18	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
UCEC	DFS	Tertile	IV	0.181	0.705	.009	18	view →
THYM	DFS	Tertile	All	0.180	0.827	.015	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-871P–LUAD (OS)

Open the LUAD breakdown →